Prolonged multimodal disease control with trifluridine/tipiracil plus bevacizumab in KRAS-mutant metastatic rectal cancer: a case report.

Anticancer DrugsJun 16, 2026 (epub)
Case ReportOncology (Medical)

Onur Alkan, Ahmet Başgöze, İsmail Nazli

✦ AI-curated · Sources linked

Case in brief

A 57-year-old man with KRAS G13D-mutant, liver-dominant metastatic rectal adenocarcinoma had recurrent coronary vasospasm associated with fluoropyrimidines, precluding 5-fluorouracil and capecitabine. Following multimodal first-line treatment and regorafenib, he received trifluridine/tipiracil plus bevacizumab, alongside liver-directed treatments for oligoprogressive disease. The combined approach provided approximately 16.6 months of disease control, with manageable hematological toxicity and preserved performance status.

What made this case unusual

Disease control was prolonged despite the inability to use 5-fluorouracil or capecitabine, with systemic trifluridine/tipiracil plus bevacizumab integrated with focal liver treatment for oligoprogression.

Diagnostic / clinical pearl

In this case, recurrent fluoropyrimidine-associated coronary vasospasm constrained systemic options; trifluridine/tipiracil plus bevacizumab with liver-directed treatment was feasible and achieved prolonged disease control.

Source

PubMed · PMID 42307975

Published in Anticancer Drugs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.